Shattuck Labs (STTK) News Today $1.00 -0.01 (-0.99%) (As of 11/22/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Shattuck Labs Focuses on Promising Antibody DevelopmentNovember 19, 2024 | markets.businessinsider.comShattuck Labs (NASDAQ:STTK) Given "Neutral" Rating at HC WainwrightNovember 18, 2024 | americanbankingnews.comShattuck Labs FY2024 EPS Estimate Decreased by HC WainwrightNovember 18, 2024 | americanbankingnews.comHC Wainwright Lowers Earnings Estimates for Shattuck LabsShattuck Labs, Inc. (NASDAQ:STTK - Free Report) - Research analysts at HC Wainwright decreased their FY2024 EPS estimates for shares of Shattuck Labs in a research report issued on Thursday, November 14th. HC Wainwright analyst J. Pantginis now expects that the company will post earnings per sharNovember 18, 2024 | marketbeat.comShattuck Labs: Navigating Strategic Shift to Autoimmune Pipeline Amidst Financial Stability and Hold RatingNovember 15, 2024 | markets.businessinsider.comTD Cowen Reaffirms Their Buy Rating on Shattuck Labs (STTK)November 15, 2024 | markets.businessinsider.comShattuck Labs' (STTK) Neutral Rating Reaffirmed at HC WainwrightHC Wainwright reissued a "neutral" rating on shares of Shattuck Labs in a report on Friday.November 15, 2024 | marketbeat.comShattuck Labs Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNovember 14, 2024 | markets.businessinsider.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc. - STTKNovember 10, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc. - STTKNovember 2, 2024 | prnewswire.comSTTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the FirmOctober 28, 2024 | businesswire.comSTTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the FirmOctober 27, 2024 | globenewswire.comShattuck Labs, Inc. (NASDAQ:STTK) Short Interest Down 60.0% in OctoberShattuck Labs, Inc. (NASDAQ:STTK - Get Free Report) was the target of a significant drop in short interest in the month of October. As of October 15th, there was short interest totalling 2,180,000 shares, a drop of 60.0% from the September 30th total of 5,450,000 shares. Based on an average daily volume of 555,700 shares, the short-interest ratio is currently 3.9 days. Currently, 5.3% of the shares of the company are sold short.October 26, 2024 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc. - STTKOctober 25, 2024 | prnewswire.comSTTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the FirmOctober 21, 2024 | globenewswire.comSTTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the FirmOctober 16, 2024 | prnewswire.comSTTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the FirmOctober 15, 2024 | globenewswire.comShattuck Labs, Inc. (NASDAQ:STTK) CEO Taylor Schreiber Buys 36,500 SharesOctober 9, 2024 | insidertrades.comShattuck Labs, Inc. (NASDAQ:STTK) CEO Purchases $44,165.00 in StockShattuck Labs, Inc. (NASDAQ:STTK - Get Free Report) CEO Taylor Schreiber bought 36,500 shares of the business's stock in a transaction on Monday, October 7th. The shares were acquired at an average price of $1.21 per share, with a total value of $44,165.00. Following the transaction, the chief executive officer now owns 71,002 shares of the company's stock, valued at $85,912.42. The trade was a 100.00 % increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.October 8, 2024 | marketbeat.comKaplan Fox & Kilsheimer LLP is Investigating Potential Securities Law Violations Against Shattuck Labs, Inc. (STTK)October 4, 2024 | theglobeandmail.comNeedham Downgrades Shattuck Labs (STTK)October 4, 2024 | msn.comHC Wainwright Comments on Shattuck Labs, Inc.'s Q3 2024 Earnings (NASDAQ:STTK)Shattuck Labs, Inc. (NASDAQ:STTK - Free Report) - Research analysts at HC Wainwright raised their Q3 2024 EPS estimates for shares of Shattuck Labs in a note issued to investors on Tuesday, October 1st. HC Wainwright analyst J. Pantginis now anticipates that the company will post earnings per shaOctober 3, 2024 | marketbeat.comHC Wainwright & Co. Downgrades Shattuck Labs (STTK)October 3, 2024 | msn.comShattuck cut to Neutral at Citi on program exitOctober 3, 2024 | seekingalpha.comShattuck Labs (NASDAQ:STTK) Downgraded to "Neutral" at CitigroupCitigroup downgraded Shattuck Labs from a "buy" rating to a "neutral" rating and reduced their target price for the stock from $8.00 to $2.00 in a report on Wednesday.October 2, 2024 | marketbeat.comShattuck Labs (NASDAQ:STTK) Stock, Short Interest ReportOctober 2, 2024 | benzinga.comShattuck Labs Refocuses Strategy Amidst Restructuring and CutsOctober 2, 2024 | finance.yahoo.comShattuck Labs Shares Touch All-Time Low on Lead Program FailureOctober 2, 2024 | marketwatch.comShattuck Labs Shutters Cancer Program, Lays Off Around 40% Of Its Workforce, Reorganizes PipelineOctober 2, 2024 | benzinga.comShattuck plunges after discontinuing lead candidateOctober 2, 2024 | seekingalpha.comShattuck Labs (NASDAQ:STTK) Stock Quotes, Forecast and News SummaryOctober 2, 2024 | benzinga.comWhy Is Shattuck Labs Stock Falling In Pre-market?October 2, 2024 | markets.businessinsider.comShattuck Labs (STTK) was downgraded to a Hold Rating at H.C. WainwrightOctober 2, 2024 | markets.businessinsider.comShattuck Labs Provides Company Update and Announces SL-325, a First-In-Class Death Receptor 3 (DR3) Antagonist Targeting the TL1A/DR3 Signaling PathwayOctober 1, 2024 | globenewswire.comShattuck Labs, Inc. (NASDAQ:STTK) is definitely on the radar of institutional investors who own 43% of the companySeptember 26, 2024 | finance.yahoo.comBank of New York Mellon Corp Has $857,000 Stock Holdings in Shattuck Labs, Inc. (NASDAQ:STTK)Bank of New York Mellon Corp boosted its position in shares of Shattuck Labs, Inc. (NASDAQ:STTK - Free Report) by 209.7% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 222,034 shares of the company's stock afSeptember 22, 2024 | marketbeat.comShattuck Labs’s SL-172154: A Novel CD47 Therapy Overcoming Previous Challenges with Promising Clinical ProspectsAugust 28, 2024 | markets.businessinsider.comShattuck Labs (NASDAQ:STTK) Receives "Buy" Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $16.00 price target on shares of Shattuck Labs in a research note on Tuesday.August 27, 2024 | marketbeat.comSTTK Dec 2024 17.500 callAugust 17, 2024 | ca.finance.yahoo.comShattuck Labs, Inc. (NASDAQ:STTK) Short Interest UpdateShattuck Labs, Inc. (NASDAQ:STTK - Get Free Report) was the target of a large increase in short interest in July. As of July 31st, there was short interest totalling 5,060,000 shares, an increase of 34.9% from the July 15th total of 3,750,000 shares. Based on an average trading volume of 457,300 shares, the short-interest ratio is presently 11.1 days. Approximately 12.3% of the shares of the company are short sold.August 17, 2024 | marketbeat.comShattuck Labs (NASDAQ:STTK) Price Target Lowered to $8.00 at CitigroupCitigroup reduced their price target on Shattuck Labs from $9.00 to $8.00 and set a "buy" rating for the company in a research report on Thursday.August 15, 2024 | marketbeat.comVanguard Group Inc. Buys 502,860 Shares of Shattuck Labs, Inc. (NASDAQ:STTK)Vanguard Group Inc. lifted its stake in Shattuck Labs, Inc. (NASDAQ:STTK - Free Report) by 38.2% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,819,926 shares of the company's stock after purchasing an additional 502,8August 13, 2024 | marketbeat.comAssessing Shattuck Labs: Insights From 7 Financial AnalystsAugust 4, 2024 | nasdaq.comBuy Rating Affirmed for Shattuck Labs Amidst Promising Therapeutic Advancements and Robust Clinical TrialsAugust 3, 2024 | markets.businessinsider.comShattuck Labs (NASDAQ:STTK) Releases Earnings Results, Misses Estimates By $0.01 EPSShattuck Labs (NASDAQ:STTK - Get Free Report) released its earnings results on Thursday. The company reported ($0.42) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.41) by ($0.01). Shattuck Labs had a negative net margin of 3,133.63% and a negative return on equity of 64.85%. The firm had revenue of $1.61 million during the quarter, compared to analysts' expectations of $0.50 million. The business's revenue for the quarter was up 704.5% on a year-over-year basis.August 2, 2024 | marketbeat.comBuy Rating Affirmed for Shattuck Labs Amid Promising AML Treatment Prospects and Strong Financial PositionAugust 2, 2024 | markets.businessinsider.comBuy Rating Affirmed for Shattuck Labs on Strong Financials and Positive Clinical Trial ProspectsAugust 2, 2024 | markets.businessinsider.comNeedham & Company LLC Reaffirms "Buy" Rating for Shattuck Labs (NASDAQ:STTK)Needham & Company LLC restated a "buy" rating and set a $8.00 target price on shares of Shattuck Labs in a report on Friday.August 2, 2024 | marketbeat.comShattuck Labs Reports Second Quarter 2024 Financial Results and Recent Business HighlightsAugust 1, 2024 | markets.businessinsider.comShattuck Labs Announces Participation in Upcoming BTIG Virtual Biotechnology ConferenceJuly 30, 2024 | globenewswire.com Get Shattuck Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for STTK and its competitors with MarketBeat's FREE daily newsletter. Email Address “Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late. STTK Media Mentions By Week STTK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. STTK News Sentiment▼-0.030.49▲Average Medical News Sentiment STTK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. STTK Articles This Week▼72▲STTK Articles Average Week Get Shattuck Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for STTK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Zura Bio News Today Compass Therapeutics News Today ADC Therapeutics News Today Opthea News Today MediWound News Today Nanobiotix News Today Caribou Biosciences News Today DiaMedica Therapeutics News Today Actuate Therapeutics News Today scPharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:STTK) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shattuck Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shattuck Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
